WHIN
Venture capitalActively deployingNew York · 1 people tracked
Find your way into WHIN
Fund manager profile
WHIN is a venture fund manager based in New York. SEC filings show 2 venture funds on record, most recently WHIN Opportunity Fund, LP filed September 2025.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directoriesWhat they invest in
from 2 of 2 portfolio companiesBiotech ×2Digital Health ×1Healthtech ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12 dated
Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.
BiotechDigital HealthHealthtechNew Haven, US
Paul Fonteyne(Co-Founder)inStephen Strittmatter(Scientific Founder)inStephen Bloch(CEO & Co-Founder)inTimothy Siegert(COO, Co-Founder)inTim Siegert, PhD(COO & Co-Founder)Jennifer Gabler(Executive Officer)in
Board seatGregory P HoGregory P. Ho· per SEC Form D · $30M raise · filed May 2026
Co-investorsElm Street VenturesSpring Mountain CapitalConnecticut Innovations
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companies
Allyx Therapeutics, Inc. · hartfordbusiness.com · Jun 15, 2026
Frequently asked questions
- Where is WHIN located?
- WHIN is headquartered in New York, US.